XML 24 R10.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Goodwill and Other Intangible Assets | 3 Months Ended
--- | ---
Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract] |
Goodwill and Intangible Assets Disclosure | 4. Goodwill and Other Intangible Assets Goodwill The following table summarizes the changes in the carrying amount of goodwill by segment and in total:
(in millions) | Pharmaceutical |  | Medical (1) |  | Total
Balance at June 30, 2022 | $ | 2,673 |  |  | $ | 3,182 |  |  | $ | 5,855 |
Foreign currency translation adjustments and other | — |  |  | (26) |  |  | (26) |
Goodwill impairment | — |  |  | (154) |  |  | (154) |
Balance at September 30, 2022 | $ | 2,673 |  |  | $ | 3,002 |  |  | $ | 5,675 |
(1)At September 30, 2022, the Medical segment accumulated goodwill impairment loss was $3.6 billion. During the three months ended September 30, 2022, the Medical Unit continued to experience adverse financial results related to inflationary impacts and PPE demand and pricing. Due to the risks and uncertainties related to these impacts and an increase in the risk-free interest rate used in the discount rate, we elected to bypass the qualitative assessment and perform quantitative goodwill impairment testing for the Medical Unit. Our determination of the estimated fair value of the Medical Unit is based on a combination of the income-based approach (using a discount rate of 10.5 percent and a terminal growth rate of 2 percent), and market-based approaches. Additionally, we assigned a weighting of 80 percent to the discounted cash flow method, 10 percent to the guideline public company method, and 10 percent to the guideline transaction method. The carrying amount exceeded the fair value, which resulted in a pre-tax impairment charge of $154 million for the Medical Unit, which was recognized during the three months ended September 30, 2022 and is included in impairments and (gain)/loss on disposal of assets, net in our condensed consolidated statements of earnings. This impairment charge was driven by an increase in the discount rate primarily due to an increase in the risk-free interest rate. The carrying value of the Medical Unit at September 30, 2022 after recognizing the impairment charge was $6.7 billion, of which $1.8 billion was goodwill. Other Intangible Assets The following tables summarize other intangible assets by class at:
| September 30, 2022
(in millions) | Gross Intangible |  | Accumulated Amortization |  | Net Intangible |  | Weighted- Average Remaining Amortization Period (Years)
Indefinite-life intangibles: |  |  |  |  |  |  |
Trademarks and patents | $ | 11 |  |  | $ | — |  |  | $ | 11 |  |  | N/A
Total indefinite-life intangibles | 11 |  |  | — |  |  | 11 |  |  | N/A
Definite-life intangibles: |  |  |  |  |  |  |
Customer relationships | 3,206 |  |  | 2,157 |  |  | 1,049 |  |  | 10
Trademarks, trade names and patents | 546 |  |  | 361 |  |  | 185 |  |  | 8
Developed technology and other | 1,037 |  |  | 590 |  |  | 447 |  |  | 9
Total definite-life intangibles | 4,789 |  |  | 3,108 |  |  | 1,681 |  |  | 9
Total other intangible assets | $ | 4,800 |  |  | $ | 3,108 |  |  | $ | 1,692 |  |  | N/A
| June 30, 2022
(in millions) | Gross Intangible |  | Accumulated Amortization |  | Net Intangible
Indefinite-life intangibles: |  |  |  |  |
Trademarks and patents | $ | 11 |  |  | $ | — |  |  | $ | 11 |
Total indefinite-life intangibles | 11 |  |  | — |  |  | 11 |
Definite-life intangibles: |  |  |  |  |
Customer relationships | 3,272 |  |  | 2,165 |  |  | 1,107 |
Trademarks, trade names and patents | 552 |  |  | 360 |  |  | 192 |
Developed technology and other | 1,038 |  |  | 574 |  |  | 464 |
Total definite-life intangibles | 4,862 |  |  | 3,099 |  |  | 1,763 |
Total other intangible assets | $ | 4,873 |  |  | $ | 3,099 |  |  | $ | 1,774 |
Total amortization of intangible assets was $71 million and $78 million for the three months ended September 30, 2022 and 2021, respectively. Estimated annual amortization of intangible assets for the remainder of fiscal 2023 through 2027 is as follows: $212 million, $258 million, $233 million, $206 million, and $174 million.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -URI https://asc.fasb.org/topic&trid=2144416 + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration